NVIDIA CORP
NVDA · Nasdaq · CIK 0001045810
SIC 3674
Semiconductors & Related Devices
Category
Electronics
Entity
operating
Incorp.
DE
Fiscal Y/E
0131
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
$219.48
+4.28 (+1.99%)
Open
$213.93
High
$222.31
Low
$213.91
Prev Close
$215.20
Volume
134,973,285
52W High
$216.82
52W Low
$110.80
50-day MA
$187.15
Quote as of: 2026-05-11
Market Cap
$4.82T
P/E
40.50
P/B
30.66
PEG
0.63
EPS
4.90
BPS
6.47
Dividend Yield
0.02%
Beta
2.34
ROE
76.33%
ROA
58.06%
D/E Ratio
0.31
Current Ratio
3.91
Gross Margin
71.07%
Operating Margin
60.38%
Net Margin
55.60%
Book Value/Share
$6.47
Intrinsic Value Estimates
Multiple valuation methods, each with its own assumptions — outputs can diverge widely
Median consensus (7 methods)
$651.87B
| Method | Implied market cap | vs current |
|---|---|---|
Graham Number √(22.5 × 순이익 × 자본) | $651.87B | +640% |
Graham Formula 순이익 × (8.5 + 2 × 성장률%) | $7.02T | -31% |
Justified P/E 순이익 × 산업 평균 P/E | $1.80T | +168% |
P/B 배수 자본 × 산업 평균 P/B | $235.94B | +1944% |
P/S 배수 매출 × 산업 평균 P/S | $431.88B | +1017% |
DCF (Gordon) CF × (1+g) / (r − g) | $3.62T | +33% |
DDM (Gordon) D × (1+g) / (r − g) | $34.41B | +13915% |
▶ Detailed analysis — formula walk-through & scenarios
Why this conclusion
Of the 7 valuation methods, 7 were applicable. Their median fair-value lands +639.9% below the current market cap → the stock trades above most formulas' estimates (overvalued). 6 methods flag overvalued, 1 flag undervalued, the rest land within fair range. Read each formula's assumptions below before treating any single number as the answer.
Graham Number
Overvalued +639.9%√(22.5 × 순이익 × 자본)
Current
$4.82T
Implied fair
$651.87B
Gap (current − fair)
+$4.17T(+639.9%)
NetIncome = $120.07B Equity = $157.29B √(22.5 × $120.07B × $157.29B) = $651.87B
- 최대 PER 15배
- 최대 PBR 1.5배
- 안정적 흑자 기업 가정 (금융·고성장 부정확)
Graham Formula
Undervalued -31.3%순이익 × (8.5 + 2 × 성장률%)
Current
$4.82T
Implied fair
$7.02T
Gap (current − fair)
$-2.20T(-31.3%)
NetIncome = $120.07B Growth g = 64.7% → cap 25.0% Multiple = 8.5 + 2 × 25.0 = 58.5× $120.07B × 58.5 = $7.02T
- EPS 성장률 64.7%/년 가정 (직전 1년 기준)
- 무성장 기업 P/E = 8.5
- 현재 적용 배수: 58.5x
Justified P/E
Overvalued +167.8%순이익 × 산업 평균 P/E
Current
$4.82T
Implied fair
$1.80T
Gap (current − fair)
+$3.02T(+167.8%)
NetIncome = $120.07B Industry P/E = 15× $120.07B × 15 = $1.80T
- 산업 평균 PER 15x 가정 (사용자 정의 가능)
- 동종 업종 비교가 핵심 — 산업별 평균 P/E 사용 권장
P/B 배수
Overvalued +1944.3%자본 × 산업 평균 P/B
Current
$4.82T
Implied fair
$235.94B
Gap (current − fair)
+$4.59T(+1944.3%)
Equity = $157.29B Industry P/B = 1.5× $157.29B × 1.5 = $235.94B
- 산업 평균 PBR 1.5x 가정
- 은행·보험·자산집약적 산업에 특히 유효
P/S 배수
Overvalued +1016.8%매출 × 산업 평균 P/S
Current
$4.82T
Implied fair
$431.88B
Gap (current − fair)
+$4.39T(+1016.8%)
Revenue = $215.94B Industry P/S = 2× $215.94B × 2 = $431.88B
- 산업 평균 PSR 2x 가정
- 매출 기반 — 적자 기업·신생 기업에 적용 가능
- 이익률 차이 무시
DCF (Gordon)
Overvalued +33.1%CF × (1+g) / (r − g)
Current
$4.82T
Implied fair
$3.62T
Gap (current − fair)
+$1.20T(+33.1%)
FCF = $102.58B Discount r = 4.0% + 5.0% = 9.0% Growth g = 6.0% $102.58B × (1 + 6.0%) / (9.0% − 6.0%) = $3.62T
- 현금흐름 입력: FCF (잉여현금흐름)
- 할인율 9.0% (무위험 4.0% + 주식위험프리미엄 5.0%)
- 영구 성장률 6.0% (실질 GDP 수준)
DDM (Gordon)
Overvalued +13915.3%D × (1+g) / (r − g)
Current
$4.82T
Implied fair
$34.41B
Gap (current − fair)
+$4.79T(+13915.3%)
Dividend D = $974.00M Discount r = 9.0% Growth g = 6.0% $974.00M × (1 + 6.0%) / (9.0% − 6.0%) = $34.41B
- 배당 입력: 실제 지급 배당
- 할인율 9.0%
- 배당 영구 성장률 6.0%
DCF sensitivity: discount rate × terminal growth
Each cell is the (current vs FCF × (1+g) / (r − g)) discount % under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +179.3% | +225.9% | +272.4% | +319.0% | +365.5% |
| 2% | +130.5% | +176.6% | +222.7% | +268.8% | +314.9% |
| 3% | +82.6% | +128.3% | +173.9% | +219.6% | +265.2% |
| 4% | +35.6% | +80.8% | +126.1% | +171.3% | +216.5% |
| 5% | -10.4% | +34.3% | +79.1% | +123.9% | +168.7% |
DDM sensitivity: discount rate × dividend growth
Each cell is the discount % vs Dividend × (1+g) / (r − g) under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +29318.3% | +34221.4% | +39124.4% | +44027.5% | +48930.5% |
| 2% | +24174.9% | +29029.9% | +33884.9% | +38739.9% | +43594.8% |
| 3% | +19131.4% | +23939.2% | +28747.1% | +33554.9% | +38362.8% |
| 4% | +14184.9% | +18946.5% | +23708.1% | +28469.7% | +33231.3% |
| 5% | +9332.5% | +14048.8% | +18765.1% | +23481.3% | +28197.6% |
All estimates rest on strong assumptions. Treat the spread, not any single number, as the signal.
Financial Statements
In USD millions (per-share figures shown directly) · Financials as of: 2026-02-25
Income Statement
| FY | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 215,938 | 130,497 | 60,922 | 26,974 | 26,914 |
| Cost of Revenue | 62,475 | 32,639 | 16,621 | 11,618 | 9,439 |
| Gross Profit | 153,463 | 97,858 | 44,301 | 15,356 | 17,475 |
| Operating Expenses | 23,076 | 16,405 | 11,329 | 11,132 | 7,434 |
| Operating Income | 130,387 | 81,453 | 32,972 | 4,224 | 10,041 |
| Net Income | 120,067 | 72,880 | 29,760 | 4,368 | 9,752 |
| EPS (Basic) | 4.93 | 2.97 | 12.05 | 1.76 | 3.91 |
| EPS (Diluted) | 4.90 | 2.94 | 11.93 | 1.74 | 3.85 |
Balance Sheet
| FY | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | 206,803 | 111,601 | 65,728 | 41,182 | 44,187 |
| Current Assets | 125,605 | 80,126 | 44,345 | 23,073 | 28,829 |
| Cash & Equivalents | 10,605 | 8,589 | 7,280 | 3,389 | 1,990 |
| Total Liabilities | 49,510 | 32,274 | 22,750 | 19,081 | 17,575 |
| Current Liabilities | 32,163 | 18,047 | 10,631 | 6,563 | 4,335 |
| Long-term Debt | 8,468 | 8,463 | 9,709 | 10,953 | 10,946 |
| Total Equity | 157,293 | 79,327 | 42,978 | 22,101 | 26,612 |
Cash Flow
| FY | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating CF | 102,718 | 64,089 | 28,090 | 5,641 | 9,108 |
| Investing CF | -52,228 | -20,421 | -10,566 | 7,375 | -9,830 |
| Financing CF | -48,474 | -42,359 | -13,633 | -11,617 | 1,865 |
| Dividends Paid | 974 | 834 | 395 | 398 | 399 |
📄 SEC Filings
Current Report
8-K
2026-05-08
Open →
Current Report
8-K
2026-04-27
Open →
Current Report
8-K
2026-03-06
Open →
Annual Report
10-K
2026-02-25
Open →
Current Report
8-K
2026-02-25
Open →
Institutional Holdings
xslForm13F_X02/primary_doc.xml
2026-02-17
Open →
Current Report
8-K
2026-01-23
Open →
Quarterly Report
10-Q
2025-11-19
Open →
Current Report
8-K
2025-11-19
Open →
Institutional Holdings
xslForm13F_X02/primary_doc.xml
2025-11-14
Open →
Other filings (90)
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-28
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-26
Open →
Insider Transaction
FORM 4
2026-03-24
Open →
Insider Transaction
FORM 4
2026-03-20
Open →
Insider Transaction
FORM 4
2026-03-20
Open →
Insider Transaction
FORM 4
2026-03-20
Open →
Insider Transaction
FORM 4
2026-03-20
Open →
Insider Transaction
FORM 4
2026-03-20
Open →
Insider Transaction
FORM 4
2026-03-20
Open →
Insider Transaction
FORM 4
2026-03-20
Open →
144
xsl144X01/primary_doc.xml
2026-03-20
Open →
144
xsl144X01/primary_doc.xml
2026-03-20
Open →
144
xsl144X01/primary_doc.xml
2026-03-20
Open →
144/A
xsl144X01/primary_doc.xml
2026-03-19
Open →
Insider Transaction
FORM 4
2026-03-19
Open →
144
xsl144X01/primary_doc.xml
2026-03-19
Open →
144
xsl144X01/primary_doc.xml
2026-03-18
Open →
Insider Transaction
FORM 4
2026-03-17
Open →
144
xsl144X01/primary_doc.xml
2026-03-13
Open →
Insider Transaction
FORM 4
2026-03-11
Open →
Insider Transaction
FORM 4
2026-03-11
Open →
Insider Transaction
FORM 4
2026-03-11
Open →
Insider Transaction
FORM 4
2026-03-11
Open →
144
xsl144X01/primary_doc.xml
2026-03-10
Open →
Insider Transaction
FORM 4
2026-03-04
Open →
Insider Transaction
FORM 4
2026-03-04
Open →
Insider Transaction
FORM 4
2026-03-04
Open →
Insider Transaction
FORM 4
2026-03-04
Open →
Insider Transaction
FORM 4
2026-03-04
Open →
Insider Transaction
FORM 4
2026-02-06
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2026-01-30
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X01/primary_doc.xml
2026-01-26
Open →
3
FORM 3
2026-01-26
Open →
Insider Transaction
FORM 4
2026-01-23
Open →
Insider Transaction
FORM 4
2026-01-23
Open →
144
xsl144X01/primary_doc.xml
2026-01-21
Open →
Insider Transaction
FORM 4
2026-01-15
Open →
Insider Transaction
FORM 4
2026-01-09
Open →
144
xsl144X01/primary_doc.xml
2026-01-07
Open →
Insider Transaction
FORM 4
2026-01-06
Open →
144
xsl144X01/primary_doc.xml
2026-01-02
Open →
Insider Transaction
FORM 4
2025-12-22
Open →
Insider Transaction
FORM 4
2025-12-22
Open →
144
xsl144X01/primary_doc.xml
2025-12-19
Open →
Insider Transaction
FORM 4
2025-12-19
Open →
Insider Transaction
FORM 4
2025-12-19
Open →
144
xsl144X01/primary_doc.xml
2025-12-19
Open →
Insider Transaction
FORM 4
2025-12-17
Open →
144
xsl144X01/primary_doc.xml
2025-12-15
Open →
Insider Transaction
FORM 4
2025-12-12
Open →
Insider Transaction
FORM 4
2025-12-12
Open →
Insider Transaction
FORM 4
2025-12-12
Open →
Insider Transaction
FORM 4
2025-12-12
Open →
Insider Transaction
FORM 4
2025-12-12
Open →
Insider Transaction
FORM 4
2025-12-12
Open →
144
xsl144X01/primary_doc.xml
2025-12-12
Open →
Insider Transaction
FORM 4
2025-12-10
Open →
Insider Transaction
FORM 4
2025-12-09
Open →
144
xsl144X01/primary_doc.xml
2025-12-09
Open →
Insider Transaction
FORM 4
2025-12-04
Open →
144
xsl144X01/primary_doc.xml
2025-12-02
Open →
Insider Transaction
FORM 4
2025-11-26
Open →
Insider Transaction
FORM 4
2025-11-26
Open →
144
xsl144X01/primary_doc.xml
2025-11-24
Open →
Insider Transaction
FORM 4
2025-11-05
Open →
Insider Transaction
FORM 4
2025-10-31
Open →
144
xsl144X01/primary_doc.xml
2025-10-29
Open →
Insider Transaction
FORM 4
2025-10-28
Open →
144
xsl144X01/primary_doc.xml
2025-10-28
Open →
144
xsl144X01/primary_doc.xml
2025-10-27
Open →
144
xsl144X01/primary_doc.xml
2025-10-24
Open →
Insider Transaction
FORM 4
2025-10-23
Open →
Insider Transaction
FORM 4
2025-10-23
Open →
144
xsl144X01/primary_doc.xml
2025-10-23
Open →
144
xsl144X01/primary_doc.xml
2025-10-22
Open →
144
xsl144X01/primary_doc.xml
2025-10-21
Open →
Insider Transaction
FORM 4
2025-10-20
Open →
144
xsl144X01/primary_doc.xml
2025-10-20
Open →
144
xsl144X01/primary_doc.xml
2025-10-17
Open →
144
xsl144X01/primary_doc.xml
2025-10-16
Open →
Insider Transaction
FORM 4
2025-10-15
Open →
144
xsl144X01/primary_doc.xml
2025-10-15
Open →
144
xsl144X01/primary_doc.xml
2025-10-14
Open →
144
xsl144X01/primary_doc.xml
2025-10-14
Open →
Insider Transaction
FORM 4
2025-10-10
Open →
144
xsl144X01/primary_doc.xml
2025-10-10
Open →
144
xsl144X01/primary_doc.xml
2025-10-09
Open →
144
xsl144X01/primary_doc.xml
2025-10-08
Open →
Insider Transaction
FORM 4
2025-10-07
Open →
144
xsl144X01/primary_doc.xml
2025-10-07
Open →